Стр. 246 - 2

Упрощенная HTML-версия

439. Ravetch, J. V. Fc receptors/ J. V. Ravetch, J. R Kinet. 1991. //Annu. Rev. Immunol.
- 1991. - Vol. 9. - R 457-492.
440. Recombinant human monoclonal antibodies to Ebola virus / T. Maruyama [et al.] //
J. Infect. Dis. - 1999. - Vol. 179 (Suppl.). - P. 235-239.
441. Recruitment and activation of PTP1C in negative regulation o f antigen receptor
signaling by Fc gamma RIIBl / D. K. D’Ambrosio [et al.] // Science. -
1995. - Vol. 268 - C. 293-297.
442. Reduction o f respiratoiy syncytial virus (RSV) in tracheal aspirates in intubated
infants by use of humanized monoclonal antibody to RSF F protein / R. Malley
[etal.] // J. Infect. D i s . - 1998.-Vol. 178.-P. 1555-1561.
443. Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor
antagonist after intravenous immunoglobulin administration in vivo / P. Aukxust
[et al.] // Blood. - 1994. - Vol. 84. - P. 2136-2142.
444. Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV
lower respiratory tract infection in infants and young children at high risk for severe
RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group /
W. J. Rodriguez [et al.] // Pediatrics. - 1997. - Vol. 99. - P. 454-461.
445. Rice, С. M. Flaviviridae: The Viruses and Their Replication / С. M. Rice //
Fields Virology / ed. by B. N. Fields [et al.]. - 3-d ed. - Philadelphia, 1996. -
P. 931-959.
446. Rinaldo, C. R. Passive Immunization Against Poliomyelitis: The Hammon Gamma
Globulin Field Trials, 1951-1953 / C. R. Rinaldo //American Journal of Public
Health. - 2005. - Vol. 95. - P. 790-799.
447. The role of antibody concentration and avidity in antiviral protection /
M. F. Bachmann [et al.] // Science. - 1997. - Vol. 276. - P. 2024-2027.
448. The role of antibody in recovery from alphavirus encephalitis / D. Griffin [et al.] //
Immunol. R ev .- 1997.-Vol. 159.-P. 155-161.
449. Salan, A. Expanding indications of statins, implications of the Heart Protecion
Study / A. Salan // Exp. Opin. Invest. - 2003. - Vol. 12, № 3. - P. 509-513.
450. Samuel, С. E. Antiviral actions of interferons / С. E. Samuel // Clin. Microbiol.
Rev. - 2001. - Vol. 14. - P. 778-809.
451. Sawaer, J. Delayed onset of encephalitis in mice passively immunized against
Semliki Forest virus / J. Sawaer, E.A. Boutler, J. Zlotnik // Brit. J. Exp.
Pathol. - 1971. - № 52, - P. 408-414.
452. Severe tick-borne encephalitis following passive immunization / K. Waldvogel
[et al.] // Eur. J. Pediatr. - 1996. - Vol. 155, № 9. - P. 775-779.
453. Shapiro, R. L. Botulism in the United States: a clinical and epidemiologic review
/ R. L. Shapiro, C. Hatheway, D. L. Swerdlow // Ann. Intern. Med. - 1998. -
Vol. 129.-P . 221-228.
454. Specific suppression of immune responses / D. A. Rowley [et al.] // Science. -
1973.-Vo l. 181.-P . 1133-1141.
455. Structure of influenza virus haemagglutinin complexed with a neutralizing antibody
/ T. Bizebard [et al.] // Nature. - 1995. - Vol. 376. - P. 92-94.
456. Sullivan, N. Ebola virus pathogenesis; implications for vaccines and
therapies / N. Sullivan, Z.-Y. Yang, G. J. Nabel // J. Virol. - 2003. - Vol. 77. -
P. 9733-9737.
457. Summary of the workshop on passive immunotherapy in the prevention and
228